MEDLAB CLINICAL LIMITED - Announcements

0.00%

$6.60

Currently unlisted.

Healthcare Biotechnology

Medlab Clinical Limited (Medlab) is an Australia-based biotechnology company. The Company... Medlab Clinical Limited (Medlab) is an Australia-based biotechnology company. The Company specializes in the application of NanoCelle drug delivery technology to existing and new pharmaceuticals with the objective of empowering patients with chronic diseases and mental health conditions and enhancing their lives. Its drug candidates include NanaBis, NanoCBD and NanoCelle. Medlab’s pipeline comprises a range of small and large molecules from repurposing generic medicines to enhancing the delivery of immunotherapies. The Company's lead drug candidate, NanaBis, is under development for cancer bone pain as an alternative to opioid use and NanoCBD for mental stress. It also has a drug delivery platform called NanoCelle, which is wholly owned by Medlab and developed in Medlab’s owned Office of the Gene Technology Regulator (OGTR) registered laboratory. It is investigating a range of prescription and non-prescription solutions for unmet patient needs across a variety of therapeutic areas.More

NATURAL MEDICINE LEADERS

The Calmer Co (ASX:CCO) FY25 Revenue Hits $8M, Up 86% on FY24

Announcements

Filter Results

All Price Sensitive Only

MDC	Appendix 4C - quarterly	PRICE SENSITIVE	30/07/20	1.67MB	Share
MDC	Section 708A Cleansing Notice		09/07/20	343.92KB	Share
MDC	Appendix 2A		08/07/20	484.57KB	Share
MDC	Completion of SPP		08/07/20	720.26KB	Share
MDC	Invitation to Virtual Research Symposium		07/07/20	680.61KB	Share
MDC	Lapse of Unlisted Options		01/07/20	647.71KB	Share
MDC	Medlab Completes First Order of New Cannabinoid to UK	PRICE SENSITIVE	29/06/20	696.83KB	Share
MDC	Reminder - Medlab Shareholder Video Conference		26/06/20	673.67KB	Share
MDC	Change in substantial holding x 3		22/06/20	1.44MB	Share
MDC	Section 708A Cleansing Notice		22/06/20	765.67KB	Share
MDC	Appendix 2A		18/06/20	484.96KB	Share
MDC	Share Purchase Plan and Invitation to Shareholder Update		17/06/20	1.18MB	Share
MDC	Section 708A Cleansing Notice		16/06/20	900.06KB	Share
MDC	Proposed issue of Securities - MDC	PRICE SENSITIVE	15/06/20	34.54KB	Share
MDC	Medlab Completes Successful $5.4m Placement	PRICE SENSITIVE	15/06/20	726.61KB	Share
MDC	NanoCBD Delivery Received and First Patient Supplied	PRICE SENSITIVE	11/06/20	836KB	Share
MDC	Company Update		11/06/20	14.5MB	Share
MDC	Trading Halt	PRICE SENSITIVE	11/06/20	766.6KB	Share
MDC	First Batches of NanaBis Delivered from Tasmanain Alkaloids		03/06/20	683.11KB	Share
MDC	Clarification to Appendix 4C		19/05/20	1.47MB	Share
MDC	Appendix 4C - quarterly	PRICE SENSITIVE	27/04/20	1.65MB	Share
MDC	MDC Extends NanoCelle Platform to Anti-Malaria Drug	PRICE SENSITIVE	21/04/20	720.17KB	Share
MDC	Trading Halt	PRICE SENSITIVE	17/04/20	752.66KB	Share
MDC	Pause in Trading	PRICE SENSITIVE	17/04/20	115.24KB	Share
MDC	Change of Director's Interest Notice		15/04/20	574.58KB	Share
MDC	Medlab Executes Nutraceutical HoA	PRICE SENSITIVE	06/04/20	680.68KB	Share
MDC	Medlab Completes Depression Trial	PRICE SENSITIVE	01/04/20	713.56KB	Share
MDC	Medlab Launches Telehealth Initiatives		18/03/20	825.03KB	Share
MDC	Clarification-RNSH NANABIS Advanced Cancer Trials		11/03/20	63.96KB	Share
MDC	p-values for Pain outcomes RNSH NanaBis Trial		11/03/20	678.21KB	Share
MDC	NanaBis Presentation	PRICE SENSITIVE	09/03/20	5.72MB	Share
MDC	Invitation - Shareholder Teleconference		09/03/20	601.91KB	Share
MDC	RNSH NanaBis Advanced Cancer Trial Results	PRICE SENSITIVE	09/03/20	1.03MB	Share
MDC	Trading Halt	PRICE SENSITIVE	05/03/20	752.61KB	Share
MDC	Half Year Accounts		26/02/20	1.93MB	Share
MDC	Appendix 4D	PRICE SENSITIVE	26/02/20	241.16KB	Share
MDC	Formal Launch of the NanaBIs Observational Study	PRICE SENSITIVE	04/02/20	725.41KB	Share
MDC	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/20	1.55MB	Share
MDC	Clarification - Agreement with Tasmanian Alkaloids Pty Ltd		29/01/20	674.17KB	Share
MDC	Agreement Signed with Tasmanian Alkaloids Pty Ltd	PRICE SENSITIVE	29/01/20	684.27KB	Share
MDC	Pharmaceutical Update		14/01/20	685.89KB	Share
MDC	Form 604		24/12/19	571.51KB	Share
MDC	Section 708A Cleansing Notice		24/12/19	343.62KB	Share
MDC	Appendix 3B		20/12/19	764.96KB	Share
MDC	Completion of Placement	PRICE SENSITIVE	16/12/19	631.12KB	Share
MDC	Clarification of Announcement - UK Expansion		13/12/19	673KB	Share
MDC	Trading Halt	PRICE SENSITIVE	13/12/19	746.99KB	Share
MDC	Medlab Enters into Distribution Agreement in the UK	PRICE SENSITIVE	12/12/19	678.63KB	Share
MDC	NanaBis Observational Study - Impressive Start	PRICE SENSITIVE	02/12/19	791.87KB	Share
MDC	Depression Trial Update	PRICE SENSITIVE	19/11/19	687.01KB	Share
MDC	Cannabis October Update - Record Income Achieved	PRICE SENSITIVE	11/11/19	710.19KB	Share
MDC	Results of Meeting		01/11/19	540.43KB	Share
MDC	Response to ASX Appendix 4C Query	PRICE SENSITIVE	01/11/19	1002KB	Share
MDC	Presentation - AGM 2019		01/11/19	9.69MB	Share
MDC	Appendix 4C - quarterly	PRICE SENSITIVE	25/10/19	1.49MB	Share
MDC	Agreement to Expand Nutraceuticals to USA Executed	PRICE SENSITIVE	10/10/19	651.44KB	Share
MDC	NanoCBD Update - First Export Order Received	PRICE SENSITIVE	02/10/19	657.26KB	Share
MDC	Notice of Annual General Meeting/Proxy Form		25/09/19	454.37KB	Share
MDC	Investor Presentation		02/09/19	1.7MB	Share
MDC	Corporate Government Statement		30/08/19	456.93KB	Share
MDC	Appendix 4G		30/08/19	604.52KB	Share
MDC	Annual Report 2019		30/08/19	14.02MB	Share
MDC	Preliminary Final Report	PRICE SENSITIVE	30/08/19	254KB	Share
MDC	MDC Successfully Completes NanaBidial Phase 1 Trial	PRICE SENSITIVE	16/08/19	648.99KB	Share
MDC	HoA Executed to Expand Nutraceuticals into the USA	PRICE SENSITIVE	05/08/19	650.12KB	Share
MDC	Appendix 4C - quarterly	PRICE SENSITIVE	30/07/19	1.53MB	Share
MDC	Notice under Section 708A(5)(e)		04/07/19	690.53KB	Share
MDC	Operations Update - Strong Increase in Revenue	PRICE SENSITIVE	04/07/19	844.95KB	Share
MDC	Appendix 3Y x 2		01/07/19	1.19MB	Share
MDC	Appendix 3B - Exercise and Lapse of Options		01/07/19	1.14MB	Share
MDC	MDC Receives Human Ethics Approval for Second NanaBis Trial	PRICE SENSITIVE	18/06/19	651.46KB	Share
MDC	Appendix 3Y		04/06/19	520.75KB	Share
MDC	MDC Executes a Heads of Agreement for NanaBis	PRICE SENSITIVE	28/05/19	652.47KB	Share
MDC	Appendix 3Y x 2		24/05/19	1.19MB	Share
MDC	Investor Presentation	PRICE SENSITIVE	02/05/19	4.85MB	Share
MDC	Appendix 4C - quarterly	PRICE SENSITIVE	30/04/19	1.51MB	Share
MDC	MDC to Collaborate with Chronic Pain Australia		16/04/19	658.83KB	Share
MDC	NanaBis Update	PRICE SENSITIVE	14/03/19	667.11KB	Share
MDC	Cleansing Statement & Appendix 3B		08/03/19	1.59MB	Share
MDC	S&P DJI Announces March 2019 Quarterly Rebalance	PRICE SENSITIVE	08/03/19	175.31KB	Share
MDC	MDC Executes HoA for NanaBis with Pharmascience Inc	PRICE SENSITIVE	05/03/19	654.07KB	Share
MDC	Half Year Accounts		22/02/19	623.91KB	Share
MDC	Appendix 4D	PRICE SENSITIVE	22/02/19	221.43KB	Share
MDC	MDC's Depression Trial Expands	PRICE SENSITIVE	14/02/19	884.91KB	Share
MDC	Appendix 4C - quarterly	PRICE SENSITIVE	30/01/19	507.76KB	Share
MDC	Medlab to Expand Nutraceutical Range into 2,100 Pharmacies	PRICE SENSITIVE	30/01/19	716.33KB	Share
MDC	MDC Receives formal SME Qualification from EMA	PRICE SENSITIVE	17/01/19	721.07KB	Share
MDC	NanoStat Demonstrates Improvement When Compared to Oral Drug	PRICE SENSITIVE	09/01/19	721.48KB	Share
MDC	Medlab - Open Day		05/12/18	1MB	Share
MDC	Medlab Expands into Europe	PRICE SENSITIVE	04/12/18	715.7KB	Share
MDC	Change in substantial holding		05/11/18	153.87KB	Share
MDC	Change in substantial holding		30/10/18	157.3KB	Share
MDC	Successful Completion of Stage 1 of NanaBis Trial	PRICE SENSITIVE	30/10/18	945.46KB	Share
MDC	Results of Meeting		26/10/18	541.42KB	Share
MDC	Appendix 4C - quarterly	PRICE SENSITIVE	26/10/18	698.19KB	Share
MDC	AGM Presentation 2018		26/10/18	5.99MB	Share
MDC	Notice of Annual General Meeting/Proxy Form		24/09/18	1.23MB	Share
MDC	Medlab Granted a Licence to Export Cannabis	PRICE SENSITIVE	11/09/18	647.95KB	Share
MDC	Independent Research Validates Science around NanoCelle	PRICE SENSITIVE	04/09/18	653.89KB	Share
MDC	Corporate Governance Statement 2018		31/08/18	461.51KB	Share

MDC Appendix 4C - quarterly
30/07/20	PRICE SENSITIVE	1.67MB	Share
MDC Section 708A Cleansing Notice
09/07/20		343.92KB	Share
MDC Appendix 2A
08/07/20		484.57KB	Share
MDC Completion of SPP
08/07/20		720.26KB	Share
MDC Invitation to Virtual Research Symposium
07/07/20		680.61KB	Share
MDC Lapse of Unlisted Options
01/07/20		647.71KB	Share
MDC Medlab Completes First Order of New Cannabinoid to UK
29/06/20	PRICE SENSITIVE	696.83KB	Share
MDC Reminder - Medlab Shareholder Video Conference
26/06/20		673.67KB	Share
MDC Change in substantial holding x 3
22/06/20		1.44MB	Share
MDC Section 708A Cleansing Notice
22/06/20		765.67KB	Share
MDC Appendix 2A
18/06/20		484.96KB	Share
MDC Share Purchase Plan and Invitation to Shareholder Update
17/06/20		1.18MB	Share
MDC Section 708A Cleansing Notice
16/06/20		900.06KB	Share
MDC Proposed issue of Securities - MDC
15/06/20	PRICE SENSITIVE	34.54KB	Share
MDC Medlab Completes Successful $5.4m Placement
15/06/20	PRICE SENSITIVE	726.61KB	Share
MDC NanoCBD Delivery Received and First Patient Supplied
11/06/20	PRICE SENSITIVE	836KB	Share
MDC Company Update
11/06/20		14.5MB	Share
MDC Trading Halt
11/06/20	PRICE SENSITIVE	766.6KB	Share
MDC First Batches of NanaBis Delivered from Tasmanain Alkaloids
03/06/20		683.11KB	Share
MDC Clarification to Appendix 4C
19/05/20		1.47MB	Share
MDC Appendix 4C - quarterly
27/04/20	PRICE SENSITIVE	1.65MB	Share
MDC MDC Extends NanoCelle Platform to Anti-Malaria Drug
21/04/20	PRICE SENSITIVE	720.17KB	Share
MDC Trading Halt
17/04/20	PRICE SENSITIVE	752.66KB	Share
MDC Pause in Trading
17/04/20	PRICE SENSITIVE	115.24KB	Share
MDC Change of Director's Interest Notice
15/04/20		574.58KB	Share
MDC Medlab Executes Nutraceutical HoA
06/04/20	PRICE SENSITIVE	680.68KB	Share
MDC Medlab Completes Depression Trial
01/04/20	PRICE SENSITIVE	713.56KB	Share
MDC Medlab Launches Telehealth Initiatives
18/03/20		825.03KB	Share
MDC Clarification-RNSH NANABIS Advanced Cancer Trials
11/03/20		63.96KB	Share
MDC p-values for Pain outcomes RNSH NanaBis Trial
11/03/20		678.21KB	Share
MDC NanaBis Presentation
09/03/20	PRICE SENSITIVE	5.72MB	Share
MDC Invitation - Shareholder Teleconference
09/03/20		601.91KB	Share
MDC RNSH NanaBis Advanced Cancer Trial Results
09/03/20	PRICE SENSITIVE	1.03MB	Share
MDC Trading Halt
05/03/20	PRICE SENSITIVE	752.61KB	Share
MDC Half Year Accounts
26/02/20		1.93MB	Share
MDC Appendix 4D
26/02/20	PRICE SENSITIVE	241.16KB	Share
MDC Formal Launch of the NanaBIs Observational Study
04/02/20	PRICE SENSITIVE	725.41KB	Share
MDC Appendix 4C - quarterly
31/01/20	PRICE SENSITIVE	1.55MB	Share
MDC Clarification - Agreement with Tasmanian Alkaloids Pty Ltd
29/01/20		674.17KB	Share
MDC Agreement Signed with Tasmanian Alkaloids Pty Ltd
29/01/20	PRICE SENSITIVE	684.27KB	Share
MDC Pharmaceutical Update
14/01/20		685.89KB	Share
MDC Form 604
24/12/19		571.51KB	Share
MDC Section 708A Cleansing Notice
24/12/19		343.62KB	Share
MDC Appendix 3B
20/12/19		764.96KB	Share
MDC Completion of Placement
16/12/19	PRICE SENSITIVE	631.12KB	Share
MDC Clarification of Announcement - UK Expansion
13/12/19		673KB	Share
MDC Trading Halt
13/12/19	PRICE SENSITIVE	746.99KB	Share
MDC Medlab Enters into Distribution Agreement in the UK
12/12/19	PRICE SENSITIVE	678.63KB	Share
MDC NanaBis Observational Study - Impressive Start
02/12/19	PRICE SENSITIVE	791.87KB	Share
MDC Depression Trial Update
19/11/19	PRICE SENSITIVE	687.01KB	Share
MDC Cannabis October Update - Record Income Achieved
11/11/19	PRICE SENSITIVE	710.19KB	Share
MDC Results of Meeting
01/11/19		540.43KB	Share
MDC Response to ASX Appendix 4C Query
01/11/19	PRICE SENSITIVE	1002KB	Share
MDC Presentation - AGM 2019
01/11/19		9.69MB	Share
MDC Appendix 4C - quarterly
25/10/19	PRICE SENSITIVE	1.49MB	Share
MDC Agreement to Expand Nutraceuticals to USA Executed
10/10/19	PRICE SENSITIVE	651.44KB	Share
MDC NanoCBD Update - First Export Order Received
02/10/19	PRICE SENSITIVE	657.26KB	Share
MDC Notice of Annual General Meeting/Proxy Form
25/09/19		454.37KB	Share
MDC Investor Presentation
02/09/19		1.7MB	Share
MDC Corporate Government Statement
30/08/19		456.93KB	Share
MDC Appendix 4G
30/08/19		604.52KB	Share
MDC Annual Report 2019
30/08/19		14.02MB	Share
MDC Preliminary Final Report
30/08/19	PRICE SENSITIVE	254KB	Share
MDC MDC Successfully Completes NanaBidial Phase 1 Trial
16/08/19	PRICE SENSITIVE	648.99KB	Share
MDC HoA Executed to Expand Nutraceuticals into the USA
05/08/19	PRICE SENSITIVE	650.12KB	Share
MDC Appendix 4C - quarterly
30/07/19	PRICE SENSITIVE	1.53MB	Share
MDC Notice under Section 708A(5)(e)
04/07/19		690.53KB	Share
MDC Operations Update - Strong Increase in Revenue
04/07/19	PRICE SENSITIVE	844.95KB	Share
MDC Appendix 3Y x 2
01/07/19		1.19MB	Share
MDC Appendix 3B - Exercise and Lapse of Options
01/07/19		1.14MB	Share
MDC MDC Receives Human Ethics Approval for Second NanaBis Trial
18/06/19	PRICE SENSITIVE	651.46KB	Share
MDC Appendix 3Y
04/06/19		520.75KB	Share
MDC MDC Executes a Heads of Agreement for NanaBis
28/05/19	PRICE SENSITIVE	652.47KB	Share
MDC Appendix 3Y x 2
24/05/19		1.19MB	Share
MDC Investor Presentation
02/05/19	PRICE SENSITIVE	4.85MB	Share
MDC Appendix 4C - quarterly
30/04/19	PRICE SENSITIVE	1.51MB	Share
MDC MDC to Collaborate with Chronic Pain Australia
16/04/19		658.83KB	Share
MDC NanaBis Update
14/03/19	PRICE SENSITIVE	667.11KB	Share
MDC Cleansing Statement & Appendix 3B
08/03/19		1.59MB	Share
MDC S&P DJI Announces March 2019 Quarterly Rebalance
08/03/19	PRICE SENSITIVE	175.31KB	Share
MDC MDC Executes HoA for NanaBis with Pharmascience Inc
05/03/19	PRICE SENSITIVE	654.07KB	Share
MDC Half Year Accounts
22/02/19		623.91KB	Share
MDC Appendix 4D
22/02/19	PRICE SENSITIVE	221.43KB	Share
MDC MDC's Depression Trial Expands
14/02/19	PRICE SENSITIVE	884.91KB	Share
MDC Appendix 4C - quarterly
30/01/19	PRICE SENSITIVE	507.76KB	Share
MDC Medlab to Expand Nutraceutical Range into 2,100 Pharmacies
30/01/19	PRICE SENSITIVE	716.33KB	Share
MDC MDC Receives formal SME Qualification from EMA
17/01/19	PRICE SENSITIVE	721.07KB	Share
MDC NanoStat Demonstrates Improvement When Compared to Oral Drug
09/01/19	PRICE SENSITIVE	721.48KB	Share
MDC Medlab - Open Day
05/12/18		1MB	Share
MDC Medlab Expands into Europe
04/12/18	PRICE SENSITIVE	715.7KB	Share
MDC Change in substantial holding
05/11/18		153.87KB	Share
MDC Change in substantial holding
30/10/18		157.3KB	Share
MDC Successful Completion of Stage 1 of NanaBis Trial
30/10/18	PRICE SENSITIVE	945.46KB	Share
MDC Results of Meeting
26/10/18		541.42KB	Share
MDC Appendix 4C - quarterly
26/10/18	PRICE SENSITIVE	698.19KB	Share
MDC AGM Presentation 2018
26/10/18		5.99MB	Share
MDC Notice of Annual General Meeting/Proxy Form
24/09/18		1.23MB	Share
MDC Medlab Granted a Licence to Export Cannabis
11/09/18	PRICE SENSITIVE	647.95KB	Share
MDC Independent Research Validates Science around NanoCelle
04/09/18	PRICE SENSITIVE	653.89KB	Share
MDC Corporate Governance Statement 2018
31/08/18		461.51KB	Share

REFRESH

First 2 3 4

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

MEDLAB CLINICAL LIMITED - Announcements

Announcements

Top Stories